Dexmedetomidine and Iatrogenic Withdrawal Syndrome in Critically Ill Children
Open Access
- 1 February 2021
- journal article
- research article
- Published by AACN Publishing in Critical Care Nurse
- Vol. 41 (1), e17-e23
- https://doi.org/10.4037/ccn2021462
Abstract
Iatrogenic withdrawal syndrome is a well-known adverse effect of sedatives and analgesics commonly used in patients receiving mechanical ventilation in the pediatric intensive care unit, with an incidence of up to 64.6%. When standard sedative and analgesic treatment is inadequate, dexmedetomidine may be added. The effect of supplemental dexmedetomidine on iatrogenic withdrawal syndrome is unclear. To explore the potentially preventive effect of dexmedetomidine, used as a supplement to standard morphine and midazolam regimens, on the development of iatrogenic withdrawal syndrome in patients receiving mechanical ventilation in the pediatric intensive care unit. This retrospective observational study used data from patients on a 10-bed general pediatric intensive care unit. Iatrogenic withdrawal syndrome was measured using the Sophia Observation withdrawal Symptoms-scale. In a sample of 102 patients, the cumulative dose of dexmedetomidine had no preventive effect on the development of iatrogenic withdrawal syndrome (P = .19). After correction for the imbalance in the baseline characteristics between patients who did and did not receive dexmedetomidine, the cumulative dose of midazolam was found to be a significant risk factor for iatrogenic withdrawal syndrome (P < .03). In this study, supplemental dexmedetomidine had no preventive effect on iatrogenic withdrawal syndrome in patients receiving sedative treatment in the pediatric intensive care unit. The cumulative dose of midazolam was a significant risk factor for iatrogenic withdrawal syndrome.Keywords
This publication has 34 references indexed in Scilit:
- Psychometric Evaluation of the Sophia Observation Withdrawal Symptoms Scale in Critically Ill ChildrenPediatric Critical Care Medicine, 2013
- Síndrome de abstinencia en Cuidados Intensivos Pediátricos. Incidencia y factores de riesgoMedicina Intensiva (English Edition), 2013
- Dexmedetomidine for opioid and benzodiazepine withdrawal in pediatric patientsAmerican Journal of Health-System Pharmacy, 2011
- Tolerance and Withdrawal From Prolonged Opioid Use in Critically Ill ChildrenPEDIATRICS, 2010
- α2-Receptor Agonists for Treatment and Prevention of Iatrogenic Opioid Abstinence Syndrome in Critically Ill PatientsAnnals of Pharmacotherapy, 2009
- The use of dexmedetomidine in critically ill childrenPediatric Critical Care Medicine, 2009
- Construction of the Sophia Observation withdrawal Symptoms-scale (SOS) for critically ill childrenIntensive Care Medicine, 2009
- Opioid and benzodiazepine withdrawal syndromes in the paediatric intensive care unit: a review of recent literatureNursing in Critical Care, 2009
- Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: A first evaluation*Critical Care Medicine, 2008
- Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: a literature review. “Assessment remains troublesome”Intensive Care Medicine, 2007